Protocol No
ALLIANCE-A032101-A-DREAM
Principal Investigator
Kathryn Bylow
Phase
II
Summary
This study is being done to answer the following question:
In patients whose cancer is responding exceptionally well to hormonal medications, can stopping treatment allow for testosterone recovery while staying off treatment for 18 months or more?
Description
Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)
Participating Institutions
Drexel Town Center
Froedtert Hospital
Froedtert West Bend Hospital
Froedtert Menomonee Falls Hospital
Status
OPEN TO ACCRUAL
Sub Category
ClinicalTrials.gov